Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. 2005

Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
Center for Pharmacogenetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

The pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) are implicated in xenobiotic and endobiotic detoxification, including the clearance of toxic bilirubin. Previous studies have suggested both overlapping and preferential regulation of target genes by these receptors, but the mechanism of cross-talk remains elusive. Here we reveal a dual role of PXR in bilirubin detoxification in that both the loss and activation of PXR led to protection from hyperbilirubinemia induced by bilirubin infusion or hemolysis. The increased bilirubin clearance in PXR-null mice was associated with selective upregulation of detoxifying enzymes and transporters, and the pattern of regulation is remarkably similar to that of transgenic mice expressing the activated CAR. Interestingly, the increased bilirubin clearance and associated gene regulation were absent in the CAR-null or double-knockout mice. In cell cultures, ligand-free PXR specifically suppressed the ability of CAR to induce the multidrug resistance associated protein 2 (MRP2), a bilirubin-detoxifying transporter. This suppression was, at least in part, the result of the disruption of ligand-independent recruitment of coactivator by CAR. In conclusion, PXR plays both positive and negative roles in regulating bilirubin homeostasis, and this provides a novel mechanism that may govern receptor cross-talk and the hierarchy of xenobiotic and endobiotic regulation. PXR is a potential therapeutic target for clinical treatment of jaundice. (HEPATOLOGY 2005;41:497-505.).

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010089 Oxidoreductases, N-Demethylating N-Demethylase,N-Demethylases,Oxidoreductases, N Demethylating,Demethylating Oxidoreductases, N,N Demethylase,N Demethylases,N Demethylating Oxidoreductases,N-Demethylating Oxidoreductases
D011987 Receptors, Steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Corticosteroid Receptors,Receptors, Corticosteroid,Steroid Receptors,Corticosteroid Receptor,Receptors, Steroids,Steroid Receptor,Receptor, Corticosteroid,Receptor, Steroid,Steroids Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D000077297 Pregnane X Receptor Steroid receptor that binds and is activated by variety of endogenous compounds and XENOBIOTICS. It binds the response element in promoters of genes that encode CYTOCHROME P450 3A4 and ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 proteins, and also activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs, and endogenous compounds. It is activated by the antibiotic RIFAMPICIN and various plant metabolites, such as hyperforin, guggulipid, colupulone, and ISOFLAVONES. NR1I2,Nuclear Receptor Subfamily 1, Group I, Member 2,SXR Receptor,Steroid X Receptor,Steroid and Xenobiotic Receptor
D000090702 Constitutive Androstane Receptor A member of the nuclear receptor superfamily (subfamily 1, group I, member 3 [NR1i3]) involved, along with PREGNANE X RECEPTOR, in regulation of cellular responses to the exogenous and endogenous chemicals such as detoxification of XENOBIOTICS. CAR Nuclear Receptor,CAR Orphan Nuclear Receptor,Constitutive Active Receptor,Constitutive Androstane Receptor beta,Active Receptor, Constitutive,Androstane Receptor, Constitutive,Nuclear Receptor, CAR,Receptor, CAR Nuclear,Receptor, Constitutive Active
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
July 2003, The Journal of nutrition,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
February 2005, Proceedings of the National Academy of Sciences of the United States of America,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
December 2017, Amino acids,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
December 2005, Drug metabolism and disposition: the biological fate of chemicals,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
January 2007, The international journal of biochemistry & cell biology,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
August 2002, European journal of pharmacology,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
May 2000, The Journal of biological chemistry,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
October 2023, Current molecular pharmacology,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
May 2003, Drug metabolism and disposition: the biological fate of chemicals,
Simrat P S Saini, and Ying Mu, and Haibiao Gong, and David Toma, and Hirdesh Uppal, and Songrong Ren, and Song Li, and Samuel M Poloyac, and Wen Xie
September 2002, Molecular pharmacology,
Copied contents to your clipboard!